Retour
66
Fourchette du Jour
1,48 €
1,53 €
Fourchette 52 Semaines
1,04 €
2,01 €
Volume
17 139 288
Moyenne 50J / 200J
1,54 €
/
1,38 €
Clôture Précédente
1,54 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,3 | 0,4 |
| P/B | 4,3 | 2,9 |
| ROE % | -33,9 | 3,9 |
| Net Margin % | -46,7 | 3,8 |
| Rev Growth 5Y % | 239,0 | 10,0 |
| D/E | 1,1 | 0,2 |
Objectif de Cours des Analystes
Hold
5,89 €
+290.1%
Low: 4,00 €
High: 8,00 €
BPA Prévisionnel
-0,04 €
CA Est.
230 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,64 €
0,58 € – 0,74 €
|
910 M | 1 |
| FY2029 |
0,42 €
0,38 € – 0,49 €
|
690 M | 1 |
| FY2028 |
0,16 €
-0,06 € – 0,60 €
|
480 M | 5 |
Points Clés
Revenue grew 238,96% annually over 5 years — strong growth
Negative free cash flow of -111,09M
PEG of 0,20 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 100,13%
Capital efficient — spends only 0,03% of revenue on capex
Croissance
Revenue Growth (5Y)
238,96%
Revenue (1Y)138,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-33,89%
ROIC-8,46%
Net Margin-46,65%
Op. Margin-29,28%
Sécurité
Debt / Equity
1,11
Current Ratio4,66
Interest Coverage-1,65
Valorisation
P/E Ratio
-11,28
P/B Ratio4,28
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 138,83% | Revenue Growth (3Y) | 2685,44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 238,96% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 183,88M | Net Income (TTM) | -85,78M |
| ROE | -33,89% | ROA | -15,04% |
| Gross Margin | 97,42% | Operating Margin | -29,28% |
| Net Margin | -46,65% | Free Cash Flow (TTM) | -111,09M |
| ROIC | -8,46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,11 | Current Ratio | 4,66 |
| Interest Coverage | -1,65 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,28 | P/B Ratio | 4,28 |
| P/S Ratio | 5,26 | PEG Ratio | 0,20 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 967,22M | Enterprise Value | 1,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 183,88M | 76,99M | 237 000,0 | 596 000,0 | 1,39M |
| Net Income | -85,78M | -174,57M | -184,13M | -141,90M | -116,11M |
| EPS (Diluted) | -0,13 | -0,27 | -0,32 | -0,37 | -0,37 |
| Gross Profit | 179,14M | 75,74M | 237 000,0 | 596 000,0 | 1,39M |
| Operating Income | -53,84M | -173,73M | -193,94M | -138,55M | -114,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 570,54M | 593,78M | 394,08M | 190,58M | 226,03M |
| Total Liabilities | 344,67M | 313,46M | 146,13M | 110,58M | 99,62M |
| Shareholders' Equity | 225,87M | 280,32M | 247,95M | 80,00M | 126,42M |
| Total Debt | 251,57M | 121,72M | 85,90M | 55,75M | 55,00M |
| Cash & Equivalents | 79,44M | 79,02M | 70,02M | 56,85M | 34,87M |
| Current Assets | 520,27M | 490,99M | 341,35M | 180,25M | 187,21M |
| Current Liabilities | 111,54M | 88,30M | 108,07M | 76,69M | 45,52M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#19 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026